OTC

Strength

18; 200; 10 mg/15mL; mg/15mL; mg/15mL

NDC

69367018408

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

4/22/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

3/15/2018

Pharmacological Classes

Adrenergic alpha1-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

+0.6%

3M

-5.6%

6M

-5.6%

1Y

-3.4%

3Y

-27.6%

5Y

-27.6%

All

-29.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.